(ℹ) Join us now at the IRC channel | ䷉ Find the plain text version at this address (HTTP) or in Gemini (how to use Gemini) with a full GemText version.
| *u-amarsh04 has quit (connection closed) | Feb 16 03:33 | |
| *u-amarsh04 (~amarsh04@qezxp5nudz5uq.irc) has joined #techbytes | Feb 16 03:33 | |
| *jacobk has quit (Ping timeout: 2m30s) | Feb 16 04:32 | |
| *jacobk (~quassel@838aynky6btpe.irc) has joined #techbytes | Feb 16 05:16 | |
| *jacobk_ (~quassel@838aynky6btpe.irc) has joined #techbytes | Feb 16 05:19 | |
| *jacobk has quit (connection closed) | Feb 16 05:19 | |
| schestowitz | "" | Feb 16 07:33 |
|---|---|---|
| schestowitz | upport at a general assembly meeting in Munich. | Feb 16 07:33 |
| schestowitz | The general assembly, which included staff representatives from EPO offices in Munich, | Feb 16 07:33 |
| schestowitz | Haar, and Brussels, voted in favour of the resolution with 416 supporting it, 4 against, and 31 | Feb 16 07:33 |
| schestowitz | abstentions. | Feb 16 07:33 |
| schestowitz | The staff resolution, passed on January 24, also proposed increasing recruitment, especially | Feb 16 07:33 |
| schestowitz | for those who perform core tasks. | Feb 16 07:33 |
| schestowitz | According to staff representatives, production targets and work pressure on staff have | Feb 16 07:33 |
| schestowitz | increased “relentlessly” in the last decade. At the same time, there has been mounting | Feb 16 07:33 |
| schestowitz | criticism from some in the industry regarding the quality of patents granted. | Feb 16 07:33 |
| schestowitz | The resolution said management should implement bottom-up planning, taking into | Feb 16 07:33 |
| schestowitz | account the “input of staff, the true available work capacity, and the time needed for | Feb 16 07:33 |
| schestowitz | peripheral but essential tasks”. | Feb 16 07:33 |
| schestowitz | Staff also argued that patent quality is directly related to work pressure. This was | Feb 16 07:33 |
| schestowitz | documented in another paper published by the office’s central staff committee (CSC), which | Feb 16 07:33 |
| schestowitz | represents EPO staff in consultative meetings with management. | Feb 16 07:33 |
| schestowitz | The CSC’s document, published on January 19, noted that ever-increasing productivity | Feb 16 07:33 |
| schestowitz | targets within the EPO did not create conditions for staff to focus on quality." | Feb 16 07:33 |
| schestowitz | https://www.managingip.com/article/2ctk7w58gs4fyg5qmpk3k/patents/epo-staff-vote-through-resolution-urging-quality-control | Feb 16 07:33 |
| -TechBytesBot/#techbytes-www.managingip.com | EPO staff vote through resolution urging quality control | Managing Intellectual Property | Feb 16 07:34 | |
| *jacobk_ has quit (Ping timeout: 2m30s) | Feb 16 08:07 | |
| *jacobk (~quassel@rj6egqhg7yiky.irc) has joined #techbytes | Feb 16 09:25 | |
| *u-amarsh04 has quit (Quit: Konversation terminated!) | Feb 16 10:13 | |
| *u-amarsh04 (~amarsh04@qezxp5nudz5uq.irc) has joined #techbytes | Feb 16 10:15 | |
| *jacobk has quit (Ping timeout: 2m30s) | Feb 16 10:15 | |
| *u-amarsh04 has quit (Quit: Konversation terminated!) | Feb 16 10:19 | |
| *u-amarsh04 (~amarsh04@qezxp5nudz5uq.irc) has joined #techbytes | Feb 16 10:20 | |
| *jacobk (~quassel@838aynky6btpe.irc) has joined #techbytes | Feb 16 10:25 | |
| *jacobk has quit (Ping timeout: 2m30s) | Feb 16 10:28 | |
| *jacobk (~quassel@32hz32it3ih2k.irc) has joined #techbytes | Feb 16 10:50 | |
| *jacobk has quit (Ping timeout: 2m30s) | Feb 16 12:12 | |
| *GNUmoon2 has quit (connection closed) | Feb 16 12:48 | |
| *GNUmoon2 (~GNUmoon@nv3iy665cbnjn.irc) has joined #techbytes | Feb 16 12:50 | |
| *schestowitz-TR has quit (Quit: Konversation term) | Feb 16 13:27 | |
| *schestowitz-TR2 has quit (Quit: Konversation term) | Feb 16 13:27 | |
| *schestowitz-TR (~acer-box@24axkg87jqny6.irc) has joined #techbytes | Feb 16 13:27 | |
| *schestowitz-TR2 (~acer-box@freenode-54p.goo.k31cok.IP) has joined #techbytes | Feb 16 13:27 | |
| *schestowitz-TR has quit (Quit: Konversation term) | Feb 16 13:33 | |
| *schestowitz-TR2 has quit (Quit: Konversation term) | Feb 16 13:33 | |
| *schestowitz-TR (~acer-box@24axkg87jqny6.irc) has joined #techbytes | Feb 16 13:33 | |
| *schestowitz-TR2 (~acer-box@freenode-54p.goo.k31cok.IP) has joined #techbytes | Feb 16 13:33 | |
| *GNUmoon2 has quit (Ping timeout: 2m30s) | Feb 16 13:34 | |
| schestowitz | http://ipkitten.blogspot.com/2024/02/board-of-appeal-proposes-substantially.html?showComment=1708014104685#c4769771168134636370 | Feb 16 13:34 |
| schestowitz | "However, this Kat is not sure that the dividing line between what is and what is not a device is yet entirely clear."</i><br /><br />The Kat is not alone. Regulatory authorities also struggle with this - see the guidance on so-called "borderline products" e.g. at<br /><br />https://www.gov.uk/guidance/borderline-products-how-to-tell-if-your-product-is-a-medical-device<br /><br />and at <br /><br />https://health.ec.europ | Feb 16 13:34 |
| schestowitz | a.eu/system/files/2022-12/md_borderline_manual_12-2022_en.pdf<br /><br />This can have implications not only for patentability but also for SPC protection, given that borderline products might be classified as a medicinal product (and thus, in principle, SPC eligible) in one country but as a medical device (and thus not SPC eligible) in another country. <br /><br />The CJEU confirmed in Boston Scientific C‑527/17 that products authori | Feb 16 13:34 |
| schestowitz | sed as medical devices are not eligible for SPC protection even though the authorisation process can include the same or similar evaluation of safety, efficacy etc. of chemical substances incorporated into those devices which would take place under the medicinal products authorisation route.<br /><br />This means that a quirk of the regulatory arrangements for borderline products can cause variation in SPC eligibility for one and the sa | Feb 16 13:34 |
| schestowitz | me product from one country to the next." | Feb 16 13:34 |
| -TechBytesBot/#techbytes-ipkitten.blogspot.com | Board of Appeal proposes a substantially broader definition of "substance or composition" in second medical use claiming (T 1252/20) - The IPKat | Feb 16 13:34 | |
| -TechBytesBot/#techbytes- ( status 404 @ https://www.gov.uk/guidance/borderline-products-how-to-tell-if-your-product-is-a-medical-device<br ) | Feb 16 13:34 | |
| -TechBytesBot/#techbytes-Could not resolve host: health.ec.europ ( status 0 @ https://health.ec.europ ) | Feb 16 13:34 | |
| schestowitz | <li><h5><a href="https://krita.org/en/posts/2024/new-krita-site/">New krita.org website launched</a></h5><blockquote><p>After a lot of work, we moved our website to a new Hugo based platform! A lot of time and energy went into making this new version. There were a number of reasons and issues that we moved the site.</p> | Feb 16 13:43 |
| schestowitz | </blockquote></li> | Feb 16 13:43 |
| -TechBytesBot/#techbytes-New krita.org website launched | Krita | Feb 16 13:43 | |
| *psydruid (~psydruid@jevhxkzmtrbww.irc) has left #techbytes | Feb 16 14:07 | |
| *psydruid (~psydruid@jevhxkzmtrbww.irc) has joined #techbytes | Feb 16 14:09 | |
| *parsifal (~parsifal@uuar9r28yasyu.irc) has joined #techbytes | Feb 16 16:27 | |
| *psydruid (~psydruid@jevhxkzmtrbww.irc) has left #techbytes | Feb 16 17:00 | |
| *psydruid (~psydruid@jevhxkzmtrbww.irc) has joined #techbytes | Feb 16 17:03 | |
| *psydroid2 (~psydroid@u8ftxtfux23wk.irc) has joined #techbytes | Feb 16 17:04 | |
| *gnulinuxuser has quit (Quit) | Feb 16 17:29 | |
| *psydruid (~psydruid@jevhxkzmtrbww.irc) has left #techbytes | Feb 16 18:04 | |
| *psydruid (~psydruid@jevhxkzmtrbww.irc) has joined #techbytes | Feb 16 18:40 | |
| *Noisytoot has quit (Ping timeout: 2m30s) | Feb 16 19:06 | |
| *parsifal has quit (Quit: Leaving) | Feb 16 21:06 | |
Generated by irclog2html.py 2.6 | ䷉ find the plain text version at this address (HTTP) or in Gemini (how to use Gemini) with a full GemText version.